Tonix Pharmaceuticals Holding Corp. cotiza a 6.64 USD y tiene una capitalización bursátil de $114M. En los últimos 12 meses ha facturado $29M con un margen de flujo de caja libre del -787.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual ta…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-2.47 | $-2.93 | $-3.98 |
| Estimado | $-2.33 | $-2.62 | $-2.54 | $-2.94 |
| Sorpresa | — | +5.7% | -15.4% | -35.4% |
| Métrica | TNXP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 49.3% | 57.0% | -7.7% |
| Operating Margin | -959.0% | -38.6% | -920.4% |
| Net Margin | -946.2% | -33.6% | -912.7% |
| FCF Margin | -787.5% | -13.9% | -773.6% |
| ROE | -50.6% | -40.4% | -10.2% |
| ROA | -44.8% | -32.0% | -12.7% |
| Current Ratio | 7.42 | 2.84 | +4.58 |
| Debt / Equity | — | 0.28 | — |